Literature DB >> 32542206

Potential dual dengue and SARS-CoV-2 infection in Thailand: A case study.

Anuttra C Ratnarathon1, Krit Pongpirul2,3, Wannarat A Pongpirul1, Lantharita Charoenpong1, Wisit Prasithsirikul1.   

Abstract

Coronavirus disease 2019 (Covid-19) has non-specific clinical and laboratory characteristics that might be similar to other viral infection including dengue. Two Covid-19 cases with 'false-positive' dengue serology have been reported in Singapore but no public health consequence was described. We describe a Thai patient with an initial diagnosis of dengue fever who was later confirmed to also infect with SARSCoV-2. The Covid-19 infection appeared to spread to one family member and one healthcare worker.
© 2020 The Author(s).

Entities:  

Keywords:  COVID-19; Dengue; Epidemiology; Infectious disease; Occupational health; Public health; SARS-CoV-2; Virology

Year:  2020        PMID: 32542206      PMCID: PMC7280131          DOI: 10.1016/j.heliyon.2020.e04175

Source DB:  PubMed          Journal:  Heliyon        ISSN: 2405-8440


Coronavirus disease 2019 (Covid-19) has non-specific clinical and laboratory characteristics [1] that might be similar to other viral infection including dengue. Two Covid-19 cases with ‘false-positive’ dengue serology have been reported in Singapore but no public health consequence was described [2]. We describe a Thai patient with an initial diagnosis of dengue fever who was later confirmed to be co-infected with SARS-CoV-2. The Covid-19 infection appeared to spread to one family member and one healthcare worker. A 35-year-old salesman with no underlying past medical history, no history of recent travel abroad, but had frequent encounters with Chinese tourists, developed a high-grade fever, myalgia, productive cough, and nausea and vomiting on January 25, 2020. He went to a local private hospital on January 28 and was prescribed some medications for his symptoms. On January 30, 2020, he went to another private hospital because his symptoms deteriorated. His blood cell counts were within normal ranges (white blood cells 7.5 × 103/ul, neutrophils 84%, lymphocytes 12%, hemoglobin 13.6 g/dl, hematocrit 39.8%, platelet 184 × 103/ul) and tested positive for both dengue IgM and IgG but negative dengue NS1 antigen. Nasopharyngeal swab tested negative for influenza A, influenza B, and respiratory syncytial virus. Chest radiography revealed minimal reticular infiltration and he was admitted for a provisional diagnosis of dengue fever. On February 2, he developed dyspnea and had persistent fever, thrombocytopenia (140 × 103/ul), lymphopenia (1.14 × 103/ul), reduced hematocrit 36.4%, and elevated alanine aminotransferase (ALT) 53 U/L (reference range 0–40 U/L). On February 3, his chest radiography showed progressive bilateral alveolar infiltration and nasopharyngeal swabs obtained from the patient tested positive for SARS-CoV-2 by real-time reverse-transcription-polymerase-chain-reaction (RT-PCR) assay performed at the Department of Medical Sciences, Ministry of Public Health. On February 5, he was referred to Bamrasnaradura Infectious Diseases Institute (BIDI) and admitted to an airborne infection isolation room (AIIR). The blood samples collected on February 3 and 5 were rechecked and tested negative for dengue virus by RT-PCR whereas dengue serology was negative for NS1 antigen and IgM but positive for IgG. Hence, recent dengue virus infection was likely. The delayed diagnosis of Covid-19 because of the positive dengue rapid tests led to spreading the virus to a 35-year-old nurse who wore gloves but did not wear a mask during the blood sampling and his 3-year-old daughter. The nurse was considered the first Thai healthcare worker who got Covid-19 infection. His wife, mother, 10 work colleagues and 24 hospital staff tested negative for Covid-19.

Informed consent

The written informed consent for service was obtained from the patient.

Declarations

Author contribution statement

All authors listed have significantly contributed to the investigation, development and writing of this article.

Funding statement

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Competing interest statement

The authors declare no conflict of interest.

Additional information

No additional information is available for this paper.
  1 in total

1.  Covert COVID-19 and false-positive dengue serology in Singapore.

Authors:  Gabriel Yan; Chun Kiat Lee; Lawrence T M Lam; Benedict Yan; Ying Xian Chua; Anita Y N Lim; Kee Fong Phang; Guan Sen Kew; Hazel Teng; Chin Hong Ngai; Li Lin; Rui Min Foo; Surinder Pada; Lee Ching Ng; Paul Anantharajah Tambyah
Journal:  Lancet Infect Dis       Date:  2020-03-04       Impact factor: 25.071

  1 in total
  5 in total

1.  Dengue and COVID-19: Managing Undifferentiated Febrile Illness during a "Twindemic".

Authors:  Liang En Wee; Edwin Philip Conceicao; Jean Xiang-Ying Sim; May Kyawt Aung; Aung Myat Oo; Yang Yong; Shalvi Arora; Indumathi Venkatachalam
Journal:  Trop Med Infect Dis       Date:  2022-05-07

2.  Concerns and public health challenges for arboviral and other respiratory infections amidst SARS-CoV-2 pandemic.

Authors:  Ankita Agarwal; Deepti Chaurasia; Paban Kumar Dash
Journal:  Pathog Glob Health       Date:  2020-09-25       Impact factor: 2.894

3.  SARS-CoV-2 and dengue virus coinfection in an adult with beta-thalassemia (trait): A case report from Bangladesh with literature review.

Authors:  Md Rezaul Hossain; Monira Sarmin; Hafizur Rahman; Lubaba Shahrin; Zannatun Nyma; Tahmeed Ahmed; Mohammod Jobayer Chisti
Journal:  Heliyon       Date:  2021-10-20

4.  Arboviruses and Their Vectors.

Authors:  Zachary J Madewell
Journal:  South Med J       Date:  2020-10       Impact factor: 0.954

5.  Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review.

Authors:  Tsheten Tsheten; Archie C A Clements; Darren J Gray; Ripon K Adhikary; Kinley Wangdi
Journal:  BMC Infect Dis       Date:  2021-08-02       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.